w4i

wings4innovation facilitates translation of biomedical innovation in Austria

Call for Proposals: If you have research results supporting a clear hypothesis for an innovative therapy in indications with high unmet need, please apply.

wings4innovation and KHAN-I technology transfer fund provide a new translation and financing paradigm for innovative drug discovery proposals from Austrian academic institutes and SMEs.

Team

Our Team

Dr. Peter Nussbaumer

Managing Director

Dr. Andreas Billich

Translational Guide

Dr. Wolfgang Sommergruber

Translational Guide

Dr. Juliane Rademacher

Translational Guide

Who we are

wings4innovation GmbH (w4i) is a subsidiary of KHAN Technology Transfer Fund I GmbH & Co. KG (KHAN-I).

KHAN-I was set up jointly by Austria Wirtschaftsservice (aws), European Investment Fund (EIF) and the Max Planck Foundation to support the translation of excellent basic research into drug development projects.

w4i scouts and evaluates project ideas and proposes suitable projects for KHAN-I funding. w4i is the central contact for academic/SME partners from all over Austria.

 

Proposals

Call for Proposals

After a successful start with already 6 Austrian projects and one company investment in the portfolio of KHAN-I, the call is still open! Researchers from Austrian academic institutes and SMEs can apply with their ideas until the end of 2023.

If you have research results supporting a clear hypothesis for an innovative therapy in indications with high unmet need, please apply!

Requirements for funding

  • Findings & hypotheses that may lead to an innovative therapy (small molecules, biologics, …) in indications with high unmet medical need
  • In-depth scientific know-how at Principal Investigator (PI)
  • Preexisting IP is not a prerequisite
  • Technical feasibility, chance for commercialisation
  • Approval by the w4i Advisory Board and the KHAN-I Investment Advisory Committee
  • Close collaboration between w4i/KHAN-I and PI

 

Portfolio

Portfolio

Partners

Framework Collaboration Partners